Preparation and characterization of dasatinib albumin micelles
	    		
		   		
		   			
		   		
	    	
    	 
    	10.11665/j.issn.1000-5048.20220305
   		
        
        	
        		- VernacularTitle:达沙替尼白蛋白胶束的制备与表征
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Wendie WANG
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Jiyuan ZHOU
			        		
			        		;
		        		
		        		
		        		
			        		Lidan TANG
			        		
			        		;
		        		
		        		
		        		
			        		Tingjie YIN
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. 南京医科大学附属常州第二人民医院药学部
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		dasatinib;
			        		
			        		
			        		
				        		albumin amphiphilic modification;
			        		
			        		
			        		
				        		albumin micelle;
			        		
			        		
			        		
				        		preparation;
			        		
			        		
			        		
				        		characterization
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Journal of China Pharmaceutical University
	            		
	            		 2022;53(3):286-292
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	In this study, a polyethylene glycol and dodecaldehyde modified bovine serum albumin (PEG-DSA) was developed, and its feasibility as a new high-efficiency micellar carrier for dasatinib (DAS) was explored.Circular dichroism, 1H NMR, elemental analysis, FT-IR and other methods were used to characterize the material structure and the single factor method was used to optimize the process of PEG-DSA/DAS micelles and non-PEGylated control micelles DSA/DAS.The results indicated that the optimal formulation was obtained with a mass ratio of 4∶1 between PEG-DSA and DAS, with average particle size of (37.21 ± 0.21) nm, polydispersion index (PDI) of (0.24 ± 0.04), Zeta potential of ? (15.68 ± 0.19) mV, drug loading (DL) capacity of (10.22 ± 0.34) %, and encapsulation efficiency (EE) of (42.73 ± 1.15) %. Compared with the currently reported nano-formulations of DAS, the drug loading of PEG-DSA/DAS micellar formulations was significantly increased with potential for further development.